Souchkevitch G N, Asikainen M, Bäuml A, Bergmann H, Busemann-Sokole E, Carlsson S, Delaloye B, Dermentzoglou F, Herrera N, Jasinski W
World Health Organization, Geneva, Switzerland.
Eur J Nucl Med. 1988;13(10):495-501. doi: 10.1007/BF00256623.
Sixteen European countries participated in this WHO-IAEA intercomparison for which transmission CAP (College of American Pathologists) thyroid and IAEA-WHO liver phantoms were used. A total of 257 laboratories submitted 428 image evaluation reports. Overall results showed differences in performance between the various countries but similarities in performance for two gamma camera subgroups defined by year of manufacture, before and after 1980. A unique review of current European liver imaging practice is presented in terms of technical parameters, imaging conditions and evaluation procedures, and quality control procedures. The WHO-IAEA intercomparison demonstrated the need to establish new, or to improve the existing, quality control programmes in certain countries. However, the large number of participating laboratories, 257 compared with 70 in the previous WHO study, (Volodin et al. 1985), shows that these international studies are serving a useful purpose in promoting quality control in nuclear medicine imaging laboratories.
16个欧洲国家参与了此次世界卫生组织-国际原子能机构的比对，其间使用了美国病理学家学会（CAP）的甲状腺模型和国际原子能机构-世界卫生组织的肝脏模型。共有257个实验室提交了428份图像评估报告。总体结果显示，各国之间在性能上存在差异，但对于按制造年份划分的两个伽马相机亚组（1980年之前和之后），性能上存在相似之处。从技术参数、成像条件、评估程序以及质量控制程序等方面，对当前欧洲肝脏成像实践进行了独特的综述。世界卫生组织-国际原子能机构的比对表明，某些国家有必要建立新的或改进现有的质量控制计划。然而，参与实验室的数量众多，与世界卫生组织之前的研究（Volodin等人，1985年）中的70个相比，此次有257个，这表明这些国际研究在促进核医学成像实验室的质量控制方面发挥了有益作用。
